Efficacy and Safety of Cefoperazone/sulbactam in Treatment of Lower Respiratory Tract Infections of Elderly: A Clinical Study Compared with Cefoperazone / 中华医院感染学杂志
Chinese Journal of Nosocomiology
;
(24)2004.
Artículo
en Chino
| WPRIM
| ID: wpr-587531
ABSTRACT
seventy) years old) with lung infections were equally divided into two groupscefoperazone/sulbactam group and cefoperazone group in a regimen of 1.0-2.0 g,twice daily for 5-14 days.RESULTS The effective rate of both agents were 100% and 80%,and their ADRs incidence rate of elderly was 4.98% and 25.00%, respectively.There were statistically significant difference(P(
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Nosocomiology
Año:
2004
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS